Ignite Creation Date:
2024-07-17 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06473259
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-28
Brief Title:
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent Alone or Combined or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
Sponsor:
Santa Chiara Hospital
Organization:
Santa Chiara Hospital
Study Overview
Official Title:
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Therapy Alone or in Combination or Radiotherapy on the Primary Tumor in Combination With Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Multicenter Observational Study of Patients Undergoing Treatment in Clinical Practice in Italian Hospitals
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECHOS
Brief Summary:
The aim of this observational study is to evaluate the clinical outcomes of treatment with docetaxel ARTA alone or in combination or with radiotherapy on the primary tumor for mCSPC in an unselected population in clinical practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None